Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GLP-1
Payers
Lilly study aims to bolster case for long-term Zepbound benefits
As questions remain about the long-term use of GLP-1s, Eli Lilly is offering a new look at how older adults fare on its medication, Zepbound.
Paige Minemyer
Aug 27, 2026 1:34pm
Employers say C-suite is getting more involved in healthcare
Aug 25, 2026 3:36pm
Berry Street, Healthify merge to scale AI-powered nutrition care
Aug 24, 2026 9:00am
Weight loss drugs reshaping healthcare's business model: report
Aug 20, 2026 9:00am
Weekly Rundown: US News ranks GLP-1 telehealth platforms
Aug 14, 2026 11:00am
Higher expenses in Q2 drive $86M loss for Hims & Hers
Aug 11, 2026 4:45pm
